Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein (MHC-HE002B)
Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein (MHC-HE002B)
Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein (MHC-HE002B)
  • Express System: E.coli
  • Product Tag: C-His-Avi
  • Purity: > 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
  • Activity: Immobilized Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer, His Tag at 1ug/ml (100ul/Well) on streptavidin(5ug/ml) precoated plate. Dose response curve for Anti-B2M Antibody, mFc Tag with the EC50 of 11.3ng/ml determined by ELISA (QC Test). See testing image for detail.
  • Amino Acid Range: Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVGAGGVGK peptide
Catalog #MHC-HE002B
Regular price $563.00
/
Size

Order now, ships by:

Product Description

Recombinant Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein is expressed from E.coli with His tag and Avi tag at the C-Terminus.It contains Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVGAGGVGK peptide.

Product Background

Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.

Product Category

Recombinant Protein

Protein

HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer

Synonyms

MHC; KRAS; K-Ras 2; KRAS2; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; KRAS1; KRAS2; NS; NS3; RASK2; GTPase Kras; KI-RAS; RALD

MHC Form

Monomer

Allele

HLA-A*11:01

Accession

Species

Human

Biotinylated

yes

Amino Acid Range

Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVGAGGVGK peptide

Molecular Weight

The protein has a predicted MW of 35.36 kDa (HLA-A*11:01) and 11.9 kDa (B2M) same as Bis-Tris PAGE result.

Activity

Immobilized Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer, His Tag at 1ug/ml (100ul/Well) on streptavidin(5ug/ml) precoated plate. Dose response curve for Anti-B2M Antibody, mFc Tag with the EC50 of 11.3ng/ml determined by ELISA (QC Test). See testing image for detail.

Product Tag

C-His-Avi

Expression System

E.coli

Purity

> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC

Endotoxin

Less than 1EU per ug by the LAL method.
Form
Liquid
Shipping
Shipped with dry ice.
Formulation
Supplied as 0.22 um filtered solution in PBS (pH 7.4).
Stability And Storage
Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Immobilized Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer, His Tag at 1ug/ml (100ul/Well) on streptavidin(5ug/ml) precoated plate. Dose response curve for Anti-B2M Antibody, mFc Tag with the EC50 of 11.3ng/ml determined by ELISA (QC Test). Immobilized Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer, His Tag at 1ug/ml (100ul/Well) on streptavidin(5ug/ml) precoated plate. Dose response curve for Anti-B2M Antibody, mFc Tag with the EC50 of 11.3ng/ml determined by ELISA (QC Test).
Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer is greater than 95% as determined by SEC-HPLC. The purity of Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer is greater than 95% as determined by SEC-HPLC.

Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Contact Us

support@kactusbio.us

Recently viewed